Xilio Therapeutics, Inc. (XLO)
NASDAQ: XLO · Real-Time Price · USD
0.8500
-0.3000 (-26.09%)
At close: May 14, 2025, 4:00 PM
0.8305
-0.0195 (-2.29%)
After-hours: May 14, 2025, 7:59 PM EDT
Xilio Therapeutics Market Cap
Xilio Therapeutics has a market cap or net worth of $44.01 million as of May 14, 2025. Its market cap has increased by 9.40% in one year.
Market Cap
44.01M
Enterprise Value
-38.85M
1-Year Change
9.40%
Ranking
Category
Stock Price
$0.85
Market Cap Chart
Since the IPO on October 22, 2021, Xilio Therapeutics's market cap has decreased from $426.71M to $44.01M, a decrease of -89.69%. That is a compound annual growth rate of -47.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2025 | 59.54M | 36.37% |
| Dec 31, 2024 | 43.66M | 188.36% |
| Dec 29, 2023 | 15.14M | -79.46% |
| Dec 30, 2022 | 73.73M | -83.14% |
| Dec 31, 2021 | 437.33M | 2.49% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.08B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |